However, whether this translates into a higher achievement of therapeutic targets is uncertain
## **Applicable modifiers** Modifiers may be required when billing for HCPCS code A9575 to clarify how the drug was used and ensure compliance with Medicare and payer-specific policies
Dec 2022;14(12):e32465
Wegovy (semaglutide 2.4 mg for chronic weight management) received FDA approval for adolescents aged 12 to 17 in December 2022, based on the STEP TEENS trial [2]
De AK, Muthiyan R, Mondal S, Mahanta N, Bhattacharya D, Ponraj P, Muniswamy K, Kundu A, Kundu MS, Sunder J, et al
of tattooed individuals report a lifestyle involving significant sun exposure (based on a questionnaire administered to 9,031 people in Brazil, of whom 1,682 had at least one tattoo)